NCT01530685
- Conditions
- Body Weight, Glucose Metabolism Disorders, Hyperglycemia, +7 more
- Locations
-
- CHU Pitié Salpetriere Paris, France
Clinical trial condition
Hyperglycemia
Explore clinical trials studying Hyperglycemia. Study availability and eligibility vary by location and protocol.
598 public trials
55 recruiting studies
Hyperglycemia trial results
NCT03318679
- Conditions
- Brain Diseases, Cardiovascular Diseases, Central Nervous System Diseases, +9 more
- Locations
-
- University of Minnesota Minneapolis, Minnesota, United States
Completed
Dipeptidyl Peptidase-4 Inhibitor (DPP4i) for the Control of Hyperglycemia in Patients With COVID-19
NCT04542213
- Conditions
- COVID-19, Coronaviridae Infections, Coronavirus Infections, +14 more
- Locations
-
- Hospital Regional de Alta Especialidad del Bajìo Leòn, Guanajuato, Mexico
NCT04554615
- Conditions
- Glucose Metabolism Disorders, Hyperglycemia, Hyperinsulinism, +6 more
- Locations
-
- Security Forces Hospital Riyadh, Saudi Arabia
NCT04015388
- Conditions
- Diabetes Mellitus, Endocrine System Diseases, Glucose Metabolism Disorders, +3 more
- Locations
-
Not specified
NCT03999632
- Conditions
- Bariatric Surgery Candidate, Diet Modification, Digestive System Diseases, +6 more
- Locations
-
- Cleveland Clinic Florida Weston, Florida, United States
Completed
Development of Agents to Diminish the Risk of Hypoglycemia-induced Brain Injury in Type 1 Diabetes
NCT03356457
- Conditions
- Glucose Metabolism Disorders, Hyperglycaemia (Diabetic), Hyperglycemia, +2 more
- Locations
-
- Yale New Haven Hospital New Haven, Connecticut, United States
Completed
Quality Gaps in Screening and Monitoring for Postoperative Hyperglycemia in a Canadian Hospital
NCT04679025
- Conditions
- Diabetes Mellitus, Endocrine System Diseases, Glucose Metabolism Disorders, +4 more
- Locations
-
- Foothills Medical Centre Calgary, Alberta, Canada
NCT04655131
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +7 more
- Locations
-
- University Hospitals Cleveland medical Center Cleveland, Ohio, United States
Completed
Effect of Dapagliflozin on Insulin Secretion and Insulin Sensitivity in Patients With Prediabetes
NCT02700334
- Conditions
- Diabetes Mellitus, Endocrine System Diseases, Glucose Intolerance, +8 more
- Locations
-
- Intstituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara Guadalajara, Jalisco, Mexico